亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

蘇州全輝生物科技有限公司  

醫藥原料及中間體生產銷售

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:劉才伙
  • 電話:0512-66368265
  • 郵件:contact@szqhbio.com
  • 傳真:0512-66368287
  • QQ:1259679610
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 蘭索拉唑 CAS號:103577-45-3
蘭索拉唑 CAS號:103577-45-3
單價 面議對比
詢價 暫無
發貨 江蘇蘇州市付款后3天內
過期 長期有效
更新 2016-02-17 09:26
 
詳細信息
 

蘭索拉唑

產品名稱:蘭索拉唑

英文名稱:Lansoprazole

化學名稱:2-[[[3-甲基-4-(2,2,2三氟乙氧基)-2-吡啶]-甲基]硫基]-1H-苯并咪唑

分子式:C16H14F3N3O2S
分子量:369.36
CAS
號:103577-45-3

質量標準:企業標準/CP2010/USP31

性狀:類白色至淡黃褐色結晶性粉末;無臭,遇光及空氣易變質;不溶于水

干燥失重:不超過1.0%

熾灼殘渣:不超過0.1%

含量:不少于99.0%

包裝:25kg;紙板桶/按客戶要求包裝

用途:消化系統類醫用原料藥

聯系方式:銷售陳:0512-66368265;18994391946;QQ1259679610contact@szqhbio.*

©2025 蘇州全輝生物科技有限公司 版權所有   技術支持:化工網   訪問量:4705  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |